Impressive Revenue and Margin Growth
In Q2, Siemens Healthineers experienced nearly 7% revenue growth and notable margin expansion, with adjusted EPS driven by topline growth. Imaging grew close to 9% with a margin uplift to 22.4%.
Strong Order Intake and Free Cash Flow
The quarter saw a strong equipment book-to-bill ratio of 1.14 and a free cash flow increase of 64% year-over-year, reaching €1 billion for the first half of fiscal year 2025.
Largest Oncology Partnership
Siemens Healthineers entered its largest value partnership worth C$800 million with Alberta, Canada, showcasing their strong position in cancer care.
Diagnostics Margin Expansion
The Diagnostics segment saw margin expansion of more than 200 basis points year-on-year to 6.3%, indicating successful operational improvements.